Search results
Results from the WOW.Com Content Network
The Bureau of Narcotics and Dangerous Drugs (BNDD) was a federal law enforcement agency within the United States Department of Justice with the enumerated power of investigating the consumption, trafficking, and distribution of narcotics and dangerous drugs. BNDD is the direct predecessor of the modern Drug Enforcement Administration (DEA). [1]
The drug or other substance has a potential for abuse less than the drugs or other substances in schedules I and II. The drug or other substance has a currently accepted medical use in treatment in the United States. Abuse of the drug or other substance may lead to moderate or low physical dependence or high psychological dependence.
The Drug Enforcement Administration is expected to approve an opinion by the Department of Health and Human Services that marijuana should be reclassified from the most strict Schedule I to the ...
But if marijuana is reclassified as a Schedule III drug, "players in that industry for the first time will be able to take standard tax deductions that other businesses take," said Paul Armentano ...
The U.S. Drug Enforcement Administration is allowing one of the nation’s largest wholesale drug distributors to stay in business, reversing an earlier order stripping the company of its licenses ...
The Drug Enforcement Administration was established on July 1, 1973, [4] by Reorganization Plan No. 2 of 1973, signed by President Richard Nixon on July 28. [5] It proposed the creation of a single federal agency to enforce the federal drug laws as well as consolidate and coordinate the government's drug control activities.
The Narcotics and Dangerous Drugs Information System, or NADDIS, is a data index and collection system operated by the United States Drug Enforcement Administration (DEA). [1] Comprising millions of DEA reports and records on individuals, NADDIS is a system by which intelligence analysts, investigators and others in law enforcement retrieve ...
The U.S. Drug Enforcement Administration’s second-in-command has quietly stepped down amid reporting by The Associated Press that he once consulted for a pharmaceutical distributor sanctioned ...